Skip to main content
Evidence-based Complementary and Alternative Medicine : eCAM logoLink to Evidence-based Complementary and Alternative Medicine : eCAM
. 2019 Jul 21;2019:5741476. doi: 10.1155/2019/5741476

Erratum to “Melatonin Suppresses the Expression of 45S Preribosomal RNA and Upstream Binding Factor and Enhances the Antitumor Activity of Puromycin in MDA-MB-231 Breast Cancer Cells”

Ji Hoon Jung 1, Eun Jung Sohn 1, Eun Ah Shin 1, Duckgue Lee 1, Bonglee Kim 1, Deok-Beom Jung 1, Ji-Hyun Kim 1, Miyong Yun 1, Hyo-Jeong Lee 1, Yong Koo Park 2, Sung-Hoon Kim 1,
PMCID: PMC6679860  PMID: 31428174

In the article titled “Melatonin Suppresses the Expression of 45S Preribosomal RNA and Upstream Binding Factor and Enhances the Antitumor Activity of Puromycin in MDA-MB-231 Breast Cancer Cells” [1], there was an error in Figure 3(a), where the fifth lane (Mcl-1) was mistakenly duplicated with the sixth lane (Cyclin D1), due to a production error. The correct figure is shown below.

Figure 3.

Figure 3

Effect of melatonin on the survival genes and apoptotic proteins in MDA-MB-231 cells. (a) Effect of melatonin on survival genes. (b) Effect of melatonin on procaspase 3 and PARP. Cells were treated with melatonin (3 mM) for 24 h. Western blotting analysis was performed with antibodies of above survival, apoptotic genes, and β-actin.

References

  • 1.Jung J. H., Sohn E. J., Shin E. A., et al. Melatonin suppresses the expression of 45S preribosomal RNA and upstream binding factor and enhances the antitumor activity of puromycin in MDA-MB-231 breast cancer cells. Evidence-Based Complementary and Alternative Medicine. 2013;2013:8. doi: 10.1155/2013/879746.879746 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Evidence-based Complementary and Alternative Medicine : eCAM are provided here courtesy of Wiley

RESOURCES